Placed Back on Formal Perfection Calendar (H)
Email me when HB 2817 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 2817. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would let Missouri award grants to in‑state entities that run FDA‑overseen ibogaine trials for opioid use disorder, other substance‑use disorders, or neurological and mental‑health conditions. It establishes an Ibogaine Study Fund and an Intellectual Property Fund, requires matching private money, and limits ibogaine prescribing to licensed physicians. The purpose is to expand treatment options for veterans and other at‑risk groups.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 2817
3 free questions a day, no accountVote
9 yes
2 no
Reported Do Pass (H) - AYES: 9 NOES: 2 PRESENT: 0 · Apr 1, 2026
History
- Placed Back on Formal Perfection Calendar (H)
- Placed on the Informal Perfection Calendar (H)
- Placed Back on Formal Perfection Calendar (H)
- Placed on the Informal Perfection Calendar (H)
- Reported Do Pass (H) - AYES: 9 NOES: 2 PRESENT: 0
- Voted Do Pass (H)
- Executive Session Completed (H)
- Referred: Rules - Legislative(H)
- HCS Reported Do Pass (H) - AYES: 8 NOES: 1 PRESENT: 2
- HCS Voted Do Pass (H)
- Executive Session Completed (H)
- Public Hearing Completed (H)
The 12 most recent of 15 recorded actions.
Sponsors
- Matthew Overcast (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 2817 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 2817 freeOr ask your AI assistant about HB 2817 directly:
Add to Claude, ChatGPT or Cursor